Cadre (CDRE) Jefferies Global Industrials Conference 2026 summary
Event summary combining transcript, slides, and related documents.
Jefferies Global Industrials Conference 2026 summary
9 Sep, 2026Business overview and evolution
Transitioned from a private company with a long heritage in public safety to a diversified industrial firm post-IPO in 2021, implementing an industrial operating model and acquiring seven companies, including five in public safety and two in nuclear safety.
Product portfolio spans body armor, duty gear (notably holsters), explosive ordnance disposal (EOD) equipment, and nuclear safety solutions such as engineered containers and alarm systems.
Maintains leading market shares in U.S. law enforcement holsters and global bomb suits, with a focus on critical, life-saving products and steady replacement cycles.
Growth drivers and market dynamics
Organic growth is sustained at the high end of a 3%-5% annual range, driven by steady law enforcement budgets, recurring replacement cycles, and new contract wins such as the FBI body armor and U.S. Special Operations Command blast sensors.
Recent contracts include a $50 million IDIQ for blast sensors and an $87 million, seven-year contract for blast attenuation seats with General Dynamics European Land Systems, expanding exposure to U.S. and European defense spending.
International expansion is supported by acquisitions like TYR Tactical, which brings significant non-U.S. revenue and advanced hard armor capabilities.
Nuclear safety segment
Nuclear safety markets are viewed as steady 4%-6% growers, with exposure to national security, environmental remediation, and commercial nuclear sectors.
Environmental remediation in the U.S. is underpinned by over $500 billion in nuclear waste cleanup needs, with consistent funding across administrations.
Commercial nuclear opportunities are emerging, particularly in fuel enrichment and containment solutions, though growth is expected to be lumpy due to project-based demand.
Latest events from Cadre
- Strong Q2 2026 results and raised FY2026 outlook reflect robust growth and successful M&A.CDRE
Investor presentation - Q2 net sales up 32%, adjusted EBITDA up 56%, record backlog, and guidance raised.CDRE
Q2 2026 - Record backlog and robust growth in safety and nuclear markets drive strong 2026 outlook.CDRE
Investor presentation - Supplement amends 2025 executive compensation details; all other proxy matters remain unchanged.CDRE
Proxy filing - Q1 2026 net sales up 19%, record backlog, and major acquisitions support strong outlook.CDRE
Q1 2026 - Proxy covers director elections, auditor ratification, executive pay, and governance practices.CDRE
Proxy filing - Strong FY2025 results and disciplined M&A fuel growth, with FY2026 sales guidance up to $758M.CDRE
Investor presentation - Record EBITDA and net income growth in 2025, with double-digit 2026 outlook and higher dividend.CDRE
Q4 2025 - Nuclear safety and engineered products drive growth, margin expansion, and resilience.CDRE
Investor Day 2025